What is it about?
This study investigates how non-neuronal cells contribute to the toxicity of the C9orf72 hexanucleotide repeat expansion—the leading genetic cause of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (ALS-FTD). While traditional research predominantly focuses on how these mutations damage neurons, this paper shifts perspective to examine the role of glial cells using Drosophila melanogaster (fruit flies) as an in vivo model organism.By systematically targeting different cell types with specific genetic drivers, the authors discovered that surface glia (the subperineurial and perineurial glia that form the fly's blood-brain barrier) are remarkably vulnerable to the disease's toxic arginine-rich dipeptide repeats (GR100). Expressing these mutant proteins specifically in surface glia induces severe developmental lethality, profound climbing/locomotor defects, and drastically shortened lifespans in adult flies.Crucially, the study demonstrates that this glial-driven degeneration occurs through unique cellular mechanisms that do not cause immediate mass cell death, and shows that a prospective drug (UDCA) which successfully rescues neuronal models actually exacerbates symptoms when targeted to glia.
Featured Image
Photo by Markus Kammermann on Unsplash
Why is it important?
We define how non-neuronal support cells, specifically surface glia, drive the development and progression of ALS-FTD genetic toxicity. This is important in neurodegenerative disease modeling to expand research beyond traditional neuron-only focused pathways. Two significant findings are that: Glial toxicity operates differently than neuronal toxicity: A drug (UDCA) known to rescue pan-neuronal models actually worsens adult locomotion and lifespan when the mutation is driven in glial cells. We propose the fly leg as a superior model: Because fly legs contain a dense, natural mix of surface glia, motor neurons, and muscles, they offer a highly reliable, high-throughput behavioral model for non-cell-autonomous disease mechanisms.
Perspectives
I hope this article makes what people might think is a rigid, neuron-centric field like ALS research, kind of interesting and maybe even exciting. Because looking strictly at neurons misses the bigger picture—support cells like the blood-brain barrier and surface glia are active, vulnerable players in neurodegeneration. The way we screen and test drug molecules needs to evaluate these complex cellular interactions. More than anything else, and if nothing else, I hope this encourages researchers to step outside the neuron and find new therapeutic pathways from the ground up.
Woo Jae Kim
Harbin Institute of Technology
Read the Original
This page is a summary of: Surface glia for modeling ALS-FTD-associated mutant C9orf72 toxicity in the nervous system of Drosophila, Genes & Diseases, March 2026, Tsinghua University Press,
DOI: 10.1016/j.gendis.2025.101629.
You can read the full text:
Contributors
The following have contributed to this page
